Podcast

Podcast: This Week in Managed Care—Tracking Drug Price Hikes and Other Health News

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

Every week, The American Journal of Managed Care® (AJMC®) recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

This week, the top managed care news included the Institute for Clinical and Economic Review investigating rising drug prices; CMS expanding value-based insurance design; and researchers using a blood test to detect preclinical Alzheimer disease.

You may need to log in to the website to access this podcast.

iTunes

TuneIn

Stitcher

Listen above or through one of these podcast services:

What's Driving US Healthcare Costs? Stakeholders Weigh In

ICER Will Review If Drug Price Hikes Are Supported by New Evidence

Report: Increasing Drug Prices, Shortages Causing Hospitals to Cut Staff, Putting Patient Safety at Risk

What We're Reading: Insulin Costs Double; PhRMA's Record Spending; Causes of Liver Transplants

CMS Expands VBID in Medicare Advantage, Increases Risk Sharing in Part D

Researchers Use Blood Test to Detect Preclinical Alzheimer Disease Signs

Improving Care for Patients With Metastatic Breast Cancer

Read more about the stories in this podcast:

Related Videos
Sam Peasah, PhD, MBA, RPh, director for the Center of High-Value Health Care at the University of Pittsburgh Medical Center (UPMC)
JC Scott, CEO and president of The Pharmaceutical Care Management Association (PCMA)
Galen Shearn-Nance, BS, and Johnie Rose, MD, PhD
Galen Shearn-Nance, BS
Dr Johnie Rose
Adam Colburn, JD, associate vice president for congressional affairs, AMCP
Tiffany Meng, PharmD, oncology pharmacist, UCSF Health
Dr Andrew S. Oseran
o Richard Hughes IV, JD, MPH, Epstein Becker Green
Dr Andrew S. Oseran
Related Content
glp-1 Wegovy, semaglutide | Image credit: Patrick Bay Damsted - stock.adobe.com
April 25th 2025

Can Medicare Sustain Widespread Access to GLP-1 Therapies?

Skylar Jeremias
Expanding Medicare coverage for glucagon-like peptide 1 (GLP-1) receptor agonists could significantly reduce obesity-related health issues, but it also risks adding tens of billions in new costs, highlighting the need for smart policy strategies to ensure access, affordability, and long-term sustainability.
managed care cast logo
April 22nd 2025

New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix

Brooke McCormick Brady Post, PhD
On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Richard Hughes IV, JD, MPH
April 21st 2025

What's at Stake as Oral Arguments Are Presented in the Braidwood Case? Q&A With Richard Hughes IV

Julia Bonavitacola Richard Hughes IV, JD, MPH
Richard Hughes IV, JD, MPH, spoke about the upcoming oral arguments to be presented to the Supreme Court regarding the Braidwood case, which would determine how preventive services are guaranteed insurance coverage.
Managed Care Cast Thumbnail
April 15th 2025

Personalized Care Key as Tirzepatide Use Expands Rapidly

Maggie L. Shaw John W. Ostrominski, MD
Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Seniors receiving health care | Image credit: Adobe.com
April 11th 2025

Sutter Health, SCAN Announce Partnership to Launch New MA Products, Joint Venture Health Plan

Mary Caffrey
The California-based entities plan to offer new Medicare Advantage (MA) products in select counties by this fall.
"Medicare Advantage" written on notepad | Image Credit: dizain - stock.adobe.com
April 7th 2025

Differential Coding Inflated Medicare Advantage Payments by $33 Billion in 2021, Study Finds

Brooke McCormick
In 2021, UnitedHealth Group received 42% of the $33 billion in additional Medicare Advantage payments from differential coding.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo